Skip to content

NexStat Plus 2gm 9430014

by Hemostasis, LLC

NexStat Plus 2gm 9430014 is a device classified as Unclassified made by Hemostasis, LLC, cleared under FDA 510(k) K122886 on 15 Nov 2012 and listed in FDA GUDID since 30 Sep 2020 (UDI-DI 00858439001262), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K122886

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00858439001262 UDI-DI Date30 Sep 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Special NumberK122886 Date15 Nov 2012DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K122886 decided 15 Nov 2012 Active
  • FDA GUDID UDI-DI 00858439001262 listed 30 Sep 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K122886
  2. Listed FDA GUDID 00858439001262

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
NexStat Plus 2gm
Generic name
Plant polysaccharide haemostatic agent, non-bioabsorbable, non-antimicrobial
Model / reference
9430014
Primary DI / UDI-DI
00858439001262
510(k) Number
FDA product code
FRO
GMDN term
Plant polysaccharide haemostatic agent, non-bioabsorbable, non-antimicrobial
Device class
U
GUDID distribution status
In Commercial Distribution
Size
Weight — 2 Gram

Similar devices

Other devices filed under FDA product code FRO (Dressing, Wound, Drug).

Other devices from Hemostasis, LLC

See all devices from Hemostasis, LLC →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)